Argentina Pharmaceuticals & Healthcare Report Q4 2013 - New Study Released
High inflation and the potential currency devaluation will continue to erode foreign pharmaceutical companies' profitability in Argentina's drug market. Furthermore, the lack of data protection and unorthodox import regulations are yet to be addressed by the local authorities. Argentina's pharmaceutical market will therefore remain unattractive to multinationals in comparison with other major Latin American drug markets. Many subsidiaries of multinational pharmaceutical companies have downscaled operations in Argentina, and local players are now using their relatively well-developed local manufacturing force to...
View full press release